| answer text |
<p>The Government’s decision not to procure Evusheld at this time was based on independent
clinical advice by the multi-agency RAPID C-19 <del class="ministerial">and a United
Kingdom national expert policy working group. RAPID C-19</del> <ins class="ministerial">.
</ins><ins class="ministerial">DHSC also </ins>sought advice from <del class="ministerial">the</del>
<ins class="ministerial">a United Kingdom national </ins>expert <ins class="ministerial">policy
</ins>working group, which includes a range of expertise including immunology, virology
and relevant specialisms such as oncology. The membership of these groups also included
experts in interpreting and analysing complex data, including clinicians and pharmacists,
evidence assessors, and researchers.</p>
|
 |
